Atopic dermatitis-associated protein interaction network lead to new insights in chronic sulfur mustard skin lesion mechanisms

References

• Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, Shoja MM. Sulfur mustard toxicity: History, chemistry, pharmacokinetics, and pharmacodynamics. Crit. Rev. Toxicol. 41(5), 384–403 (2011).
   PubMed Web of Science ®Google Scholar
• Uhde GI. Mustard-gas burns of human eyes in World War II. Am. J. Ophthalmol. 29, 929–938 (1946).
   PubMedGoogle Scholar
• Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam. Clin. Pharmacol. 19(3), 297–315 (2005).
   PubMed Web of Science ®Google Scholar
• Balali M, Navaiean A. Clinical and practical findings in 232 patients with sulfur mustard poisoning. In: Second World Congress on New Compounds in Biologic and Chemical Warfare. Heyndricks B ( Ed.). Rijksuniversiteit, Ghent, Belgium, 464–473 (1986).
   Google Scholar
• Mellor SG, Rice P, Cooper GJ. Vesicant burns. Br. J. Plast. Surg. 44(6), 434–437(1991).
   PubMedGoogle Scholar
• Shakarjian MP, Heck DE, Gray JP et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 114(1), 5–19 (2010).
   PubMed Web of Science ®Google Scholar
• Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T. Acute effects of sulfur mustard injury--Munich experiences. Toxicology 263(1), 3–8 (2009).
   PubMed Web of Science ®Google Scholar
• Kehe K, Thiermann H. Clinical picture of sulfur mustard poisoning. Toxicology 263(1), 1–1 (2009).
   PubMedGoogle Scholar
• Petrali JP, Oglesby SB, Meier HL. Ultrastructural correlates of the protection afforded by niacinamide against sulfur mustard-induced cytotoxicity of human lymphocytes in vitro. Ultrastruct. Pathol. 14(3), 253–262 (1990).
   PubMed Web of Science ®Google Scholar
• Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 214(3), 198–209 (2005).
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol 99(4), 273–282 (2006).
   PubMed Web of Science ®Google Scholar
• Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J. Occup. Environ. Med. 45(11), 1136–1143 (2003).
   PubMed Web of Science ®Google Scholar
• Upham JW, Holt PG. Environment and development of atopy. Curr. Opin. Allergy Clin. Immunol. 5(2), 167–172 (2005).
   PubMedGoogle Scholar
• Blumenthal MN. The role of genetics in the development of asthma and atopy. Curr. Opin. Allergy Clin. Immunol. 5(2), 141–145 (2005).
   PubMedGoogle Scholar
• Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation. Arch Dermatol, 144(8), 1059–1061 (2008).
   PubMedGoogle Scholar
• Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16–20 years after exposure. Int J Dermatol, 45(9), 1025–1031 (2006).
   PubMedGoogle Scholar
• Balali-Mood M, Hefazi M, Mahmoudi M et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam. Clin. Pharmacol. 19(6), 713–721 (2005).
   PubMedGoogle Scholar
• Emadi SN, Kaffashi M, Poursaleh Z et al. Sulfur mustard-induced poikiloderma: A case report. Cutan. Ocul. Toxicol. 30(2), 170–174 (2011).
   PubMed Web of Science ®Google Scholar
• Rodríguez E, Baurecht H, Herberich E et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J. Allergy Clin. Immunol. 123(6), 1361–1370.e1367 (2009).
   PubMedGoogle Scholar
• Palmer CNA, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38(4), 441–446 (2006).
   PubMed Web of Science ®Google Scholar
• Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 124(3 Suppl. 2), R7–R12 (2009).
   PubMed Web of Science ®Google Scholar
• Hansson L, Bäckman A, Ny A et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol. 118(3), 444–449 (2002).
   PubMed Web of Science ®Google Scholar
• Weidinger S, Gieger C, Rodriguez E et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet. 4(8), e1000166 (2008).
   Web of Science ®Google Scholar
• Vasilopoulos Y, Cork MJ, Murphy R et al. Genetic association between an AACC insertion in the 3’UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J. Invest. Dermatol. 123(1), 62–66 (2004).
   PubMed Web of Science ®Google Scholar
• O’Regan GM, Campbell LE, Cordell HJ, Irvine AD, McLean WHI, Brown SJ. Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J. Allergy Clin. Immunol. 125(1), 170–174.e171–172 (2010).
   PubMedGoogle Scholar
• Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 9(5), 437–446 (2009).
   PubMed Web of Science ®Google Scholar
• Briot A, Deraison C, Lacroix M et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 206(5), 1135–1147 (2009).
   PubMed Web of Science ®Google Scholar
• Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 365(14), 1315–1327 (2011).
   PubMed Web of Science ®Google Scholar
• Meier HL, Gross CL, Papirmeister B. 2,2’-Dichlorodiethyl sulfide (sulfur mustard) decreases NAD+ levels in human leukocytes. Toxicol. Lett. 39(1), 109–122 (1987).
   PubMedGoogle Scholar
• Pearson GS. Veterans at Risk: The Health Effects of Mustard Gas and Lewisite.Constance M P, David PR ( Eds.). Nature 365(6443), 218–218 (1993).
   Google Scholar
• Dabrowska MI, Becks LL, Lelli JL, Levee MG, Hinshaw DB. Sulfur mustard induces apoptosis and necrosis in endothelial cells. Toxicol. Appl. Pharmacol. 141(2), 568–583 (1996).
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci. 23(15), 6176–6180 (2003).
   PubMed Web of Science ®Google Scholar
• Tsuruta J, Sugisaki K, Dannenberg AM, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 20(3), 293–318 (1996).
   PubMedGoogle Scholar
• Sabourin CLK, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J. Biochem. Mol. Toxicol. 16(6), 263–272 (2002).
   PubMedGoogle Scholar
• Grobe K, Pöppelmann M, Becker WM, Petersen A. Properties of group I allergens from grass pollen and their relation to cathepsin B, a member of the C1 family of cysteine proteinases. Eur. J. Biochem. 269(8), 2083–2092 (2002).
   PubMedGoogle Scholar
• Umeuchi H, Togashi Y, Honda T et al. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur. J. Pharmacol. 477(1), 29–35 (2003).
   PubMed Web of Science ®Google Scholar
• Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol. Sci. 19(3), 94–98 (1998).
   PubMed Web of Science ®Google Scholar
• Nakao K, Ikeda K, Kurokawa T et al. [Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis]. Nihon Shinkei Seishin Yakurigaku Zasshi 28(2), 75–83 (2008).
   PubMedGoogle Scholar
• Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J. Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J. Invest. Dermatol. 114(6), 1108–1112 (2000).
   PubMedGoogle Scholar
• Greaves MW, McDonald-Gibson W. Itch: role of prostaglandins. Br. Med. J. 3(5881), 608–609 (1973).
   PubMedGoogle Scholar
• Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev. 19(5–6), 347–356).
   PubMedGoogle Scholar
• Sonkoly E, Muller A, Lauerma AI et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol. 117(2), 411–417 (2006).
   PubMed Web of Science ®Google Scholar
• Neis MM, Peters B, Dreuw A et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J. Allergy Clin. Immunol. 118(4), 930–937 (2006).
   PubMed Web of Science ®Google Scholar
• Nordlind K, Chin LB, Ahmed AA, Brakenhoff J, Theodorsson E, Lidén S. Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin. Arch. Dermatol. Res. 288(8), 431–435 (1996).
   PubMedGoogle Scholar
• Jafari M, Primo V, Smejkal GB, Moskovets EV, Kuo WP, Ivanov AR. Comparison of in-gel protein separation techniques commonly used for fractionation in mass spectrometry-based proteomic profiling. Electrophoresis 33(16), 2516–2526 (2012).
   PubMedGoogle Scholar
• Hou J, Chi X. Predicting protein functions from PPI networks using functional aggregation. Math Biosci. 240(1), 63–69 (2012).
   PubMedGoogle Scholar
• Hishigaki H, Nakai K, Ono T, Tanigami a, Takagi T. Assessment of prediction accuracy of protein function from protein--protein interaction data. Yeast. 18(6), 523–531 (2001).
   PubMed Web of Science ®Google Scholar
• Deng M, Zhang K, Mehta S, Chen T, Sun F. Prediction of protein function using protein-protein interaction data. Proc. IEEE Comput. Soc. Bioinform. Conf. 1(6), 197–206 (2002).
   PubMedGoogle Scholar
• Brun C, Chevenet F, Martin D, Wojcik J, Guénoche A, Jacq B. Functional classification of proteins for the prediction of cellular function from a protein-protein interaction network. Genome. Biol. 5(1), R6–R6 (2003).
   Google Scholar
• Jansen BJH, Schalkwijk J. Transcriptomics and proteomics of human skin. Brief Funct. Genomic Proteomic. 1(4), 326–341 (2003).
   PubMedGoogle Scholar
• Huang C-m, Foster KW, DeSilva T et al. Comparative proteomic profiling of murine skin. J. Invest. Dermatol. 121(1), 51–64 (2003).
   PubMed Web of Science ®Google Scholar
• Carlén LM, Sánchez F, Bergman A-C et al. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J. Invest. Dermatol. 124(1), 63–69 (2005).
   PubMedGoogle Scholar
• Yoon SW, Kim TY, Sung MH, Kim CJ, Poo H. Comparative proteomic analysis of peripheral blood eosinophils from healthy donors and atopic dermatitis patients with eosinophilia. Proteomics 5(7), 1987–1995 (2005).
   PubMed Web of Science ®Google Scholar
• Park Y-D, Park D, Bhak J, Yang J-M. Proteomic approaches to the analysis of atopic dermatitis and new insights from interactomics. Proteomics Clin. Appl. 2(3), 290–300 (2008).
   PubMedGoogle Scholar
• Park YD, Lyou YJ, Yang JM. Two-dimensional electrophoresis analyses of atopic dermatitis and the chances to detect new candidate proteins by the variations in immobilized pH gradient strips. J. Dermatol. Sci. 47(1), 9–17 (2007).
   PubMed Web of Science ®Google Scholar
• Park Y-D, Kim S-y, Jang H-S et al. Towards a proteomic analysis of atopic dermatitis: A two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics 4(11), 3446–3455 (2004).
   PubMed Web of Science ®Google Scholar
• Kim WK, Hwang H-R, Kim DH et al. Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers. Exp. Mol. Med. 40(6), 677–677 (2008).
   PubMed Web of Science ®Google Scholar
• Kim WK, Cho HJ, Ryu SI et al. Comparative proteomic analysis of peripheral blood mononuclear cells from atopic dermatitis patients and healthy donors. BMB Rep. 41(8), 597–603 (2008).
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Kato H, Asahi Y, Sugita T, Nishikawa A. Identification of the major allergen of Malassezia globosa relevant for atopic dermatitis. J. Dermatol. Sci. 55(3), 185–192 (2009).
   PubMedGoogle Scholar
• Broccardo CJ, Mahaffey S, Schwarz J et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J. Allergy Clin. Immunol. 127(1), 186–193, 193.e181–111 (2011).
   PubMed Web of Science ®Google Scholar
• El-Rachkidy RG, Hales JM, Freestone PPE, Young HS, Griffiths CEM, Camp RDR. Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis. J. Invest. Dermatol. 127(6), 1337–1342 (2007).
   PubMedGoogle Scholar
• Carlén L, Sakuraba K, Ståhle M, Sánchez F. HLA-C expression pattern is spatially different between psoriasis and eczema skin lesions. J. Invest. Dermatol. 127(2), 342–348 (2007).
   PubMed Web of Science ®Google Scholar
• Ariza M-E, Williams MV. A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis? J. Invest. Dermatol. 131(12), 2419–2427 (2011).
   PubMed Web of Science ®Google Scholar
• Fernandez-Flores A. CD10 immunohistochemistry in prurigo nodularis. Histopathology 52(5), 642–643 (2008).
   PubMedGoogle Scholar
• Brown SJ, McLean WHI. Eczema genetics: current state of knowledge and future goals. J. Invest. Dermatol. 129(3), 543–552 (2009).
   PubMedGoogle Scholar
• Jafari M, Masoudi-Nejad A. Proteomics Databases and Websites. JPS 3(3), 44–51 (2012).
   Google Scholar
• von Mering C, Jensen LJ, Kuhn M et al. STRING 7--recent developments in the integration and prediction of protein interactions. Nucleic Acids Res. 35(Database issue), D358–D362 (2007).
   Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39(Database issue), D561–D568 (2011).
   PubMed Web of Science ®Google Scholar
• Van Hemert JL, Dickerson JA. Pathway access: Cell designer plugins for pathway databases. Bioinformatics 26(18), 2345–2346 (2010).
   PubMedGoogle Scholar
• Cline MS, Smoot M, Cerami E et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2(10), 2366–2382 (2007).
   PubMed Web of Science ®Google Scholar
• Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. International Association for the Advancement of Artificial Intelligence. Paris, France, 2009
   Google Scholar
• Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3), 431–432 (2011).
   PubMed Web of Science ®Google Scholar
• Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21(16), 3448–3449 (2005).
   PubMed Web of Science ®Google Scholar
• Jafari M, Mirzaie M, Sadeghi M, Marashi S-A, Rezaei-Tavirani M. Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data. Biochim. Biophys. Acta. 1834(6), 1063–1069 (2013).
   PubMedGoogle Scholar
• Yu Qb, Li G, Wang G et al. Construction of a chloroplast protein interaction network and functional mining of photosynthetic proteins in Arabidopsis thaliana. Cell. Res. 18(10), 1007–1019 (2008).
   PubMedGoogle Scholar
• del Sol A, Fujihashi H, O’Meara P. Topology of small-world networks of protein-protein complex structures. Bioinformatics 21(8), 1311–1315 (2005).
   PubMedGoogle Scholar
• Simonsson C, Andersson SI, Stenfeldt AL et al. Caged fluorescent haptens reveal the generation of cryptic epitopes in allergic contact dermatitis. J. Invest. Dermatol. 131(7), 1486–1493 (2011).
   PubMedGoogle Scholar
• Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 263(1), 9–11 (2009).
   PubMed Web of Science ®Google Scholar
• Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. Basic Clin. Pharmacol Toxicol. 104(2), 171–175 (2009).
   PubMedGoogle Scholar
• Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int. J. Dermatol. 47(6), 557–561 (2008).
   PubMedGoogle Scholar
• Mehrani H, Ghanei M, Aslani J, Golmanesh L. Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin. Appl. 3(10), 1191–1200 (2009).
   PubMed Web of Science ®Google Scholar
• Lee SH, Miyamoto K, Goto T, Oe T. Non-invasive proteomic analysis of human skin keratins: screening of methionine oxidation in keratins by mass spectrometry. J. Proteomics. 75(2), 435–449 (2011).
   PubMed Web of Science ®Google Scholar
• Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H. Sulfur mustard research--strategies for the development of improved medical therapy. Eplasty 8, e32–e32 (2008).
   PubMedGoogle Scholar
• Iyriboz Y. A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure. Med. Gen. Med. 6(4), 4–4 (2004).
   PubMedGoogle Scholar
• Mishra NC, Rir-sima-ah J, March T et al. Sulfur mustard induces immune sensitization in hairless guinea pigs. Int. Immunopharmacol. 10(2), 193–199 (2010).
   PubMed Web of Science ®Google Scholar
• Mehrani H, Ghanei M, Aslani J, Tabatabaei Z. Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis. Clin. Proteomics. 8(1), 2–2 (2011).
   PubMedGoogle Scholar
• Khaheshi I, Keshavarz S, Imani Fooladi AA et al. Loss of expression of TGF-βs and their receptors in chronic skin lesions induced by sulfur mustard as compared with chronic contact dermatitis patients. BMC Dermatol. 11(1), 2–2 (2011).
   PubMedGoogle Scholar
• Emadi SN, Hosseini-Khalili A, Soroush M et al. External urethral stenosis: a latent effect of sulfur mustard two decades post-exposure. Int. J. Dermatol. 48(9), 960–963 (2009).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Mooney SD. Functional organization and its implication in evolution of the human protein-protein interaction network. BMC Genomics. 13(1), 150–150 (2012).
   PubMedGoogle Scholar
• Stelzl U, Worm U, Lalowski M et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122(6), 957–968 (2005).
   PubMed Web of Science ®Google Scholar
• Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Müller T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 24(13), i223–i231 (2008).
   Google Scholar
• Chen J, Yuan B. Detecting functional modules in the yeast protein-protein interaction network. Bioinformatics 22(18), 2283–2290 (2006).
   Google Scholar
• Brodsky B, Trivedi S, Peddada S, Flagler N, Wormser U, Nyska A. Early effects of iodine on DNA synthesis in sulfur mustard-induced skin lesions. Arch. Toxicol. 80(4), 212–216 (2006).
   PubMedGoogle Scholar
• Chakrabarti AK, Ray P, Broomfield CA, Ray R. Purification and characterization of protease activated by sulfur mustard in normal human epidermal keratinocytes. Biochem. Pharmacol. 56(4), 467–472 (1998).
   PubMedGoogle Scholar
• Arroyo CM, Burman DL, Kahler DW et al. TNF-alpha expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L). Cell. Biol. Toxicol. 20(6), 345–359 (2004).
   PubMedGoogle Scholar
• Clayson ET, Kelly SA, Meier HL. Effects of specific inhibitors of cellular functions on sulfur mustard-induced cell death. Cell. Biol. Toxicol. 9(2), 165–175 (1993).
   PubMedGoogle Scholar
• Brimfield AA, Zweig LM, Novak MJ, Maxwell DM. In vitro oxidation of the hydrolysis product of sulfur mustard, 2,2’-thiobis-ethanol, by mammalian alcohol dehydrogenase. J Biochem Mol. Toxicol, 12(6), 361–369 (1998).
   PubMedGoogle Scholar
• Dolado I, Nebreda AR. AKT and oxidative stress team up to kill cancer cells. Cancer Cell, 14(6), 427–429 (2008).
   PubMedGoogle Scholar
• Swami M. Therapeutics: Akt: a double-edged sword. Nat Rev Cancer 9(2), 76–77 (2008).
   Google Scholar
• Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 129(7), 1261–1274 (2007).
   PubMed Web of Science ®Google Scholar
• Essafi A, Gomes AR, Pomeranz KM et al. Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol. Biol. 462, 201–211 (2009).
   PubMedGoogle Scholar
• Vojtek AB, Taylor J, DeRuiter SL et al. Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol. Cell. Biol. 23(13), 4417–4427 (2003).
   PubMed Web of Science ®Google Scholar
• Mendoza-Gamboa E, Siwak DR, Tari AM. The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. Oncol. Rep. 12(4), 903–908 (2004).
   PubMedGoogle Scholar
• Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3(3), 245–252 (2001).
   PubMedGoogle Scholar
• Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci, 116(Pt 15), 3051–3060 (2003).
   PubMed Web of Science ®Google Scholar
• Ouyang W, Li J, Ma Q, Huang C. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 27(4), 864–873 (2006).
   PubMed Web of Science ®Google Scholar
• Rössig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21(16), 5644–5657 (2001).
   PubMedGoogle Scholar
• Dinarello CA. Proinflammatory cytokines. Chest, 118(2), 503–508 (2000).
   PubMed Web of Science ®Google Scholar
• Mas AE, Petitbarat M, Dubanchet S, Fay S, Ledée N, Chaouat G. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am. J. Reprod. Immunol. 59(4), 323–338 (2008).
   PubMedGoogle Scholar
• Ikeda R, Moriyama M, Nakade T, Tsugawa R, Suzuki K. The relationship between the production of interleukin-6 and the proliferating cell nuclear antigen (PCNA) expression in renal cell carcinoma. Hinyokika Kiyo 44(4), 233–238 (1998).
   PubMedGoogle Scholar
• Hodge DR, Cho E, Copeland TD et al. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics, 4(6), 387–398).
   PubMedGoogle Scholar
• Berg DT, Gupta A, Richardson MA, O’Brien LA, Calnek D, Grinnell BW. Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J. Biol. Chem. 282(51), 36837–36844 (2007).
   PubMedGoogle Scholar
• Li AG, Lu S-L, Han G, Hoot KE, Wang X-J. Role of TGFbeta in skin inflammation and carcinogenesis. Mol. Carcinog. 45(6), 389–396 (2006).
   PubMedGoogle Scholar
• Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-β family in wound healing, burns and scarring: a review. Int. J. Burns. Trauma. 2(1), 18–28 (2012).
   PubMedGoogle Scholar
• Suwanabol PA, Seedial SM, Zhang F et al. TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 302(11), H2211–H2219 (2012).
   Google Scholar
• Band AM, Björklund M, Laiho M. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7. J. Biol. Chem. 284(51), 35441–35449 (2009).
   PubMedGoogle Scholar
• Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274(33), 23013–23019 (1999).
   PubMedGoogle Scholar
• Kanwar AJ, De D. Epidemiology and clinical features of atopic dermatitis in India. Indian J. Dermatol. 56(5), 471–475 (2011).
   PubMedGoogle Scholar
• Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J. Invest. Dermatol. 131(1), 67–73 (2011).
   PubMed Web of Science ®Google Scholar
• Zafarghandi MR, Soroush MR, Mahmoodi M et al. Incidence of cancer in Iranian sulfur mustard exposed veterans: a long-term follow-up cohort study. Cancer Causes Control: CCC 24(1), 99–105 (2013).
   PubMedGoogle Scholar